Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

OrganoClick: Last quarter of tough comps in NW&FT - ABG

OrganoClick

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Report out 6 May
Q1e: sales SEK 39m, +2% y-o-y, EBIT SEK 0.5m (0.2m)
Optimistic on GC&MP, cautious on FW & NW&FT


Q1 expectations

For Q1, we estimate sales of SEK 39m, up 1.5% y-o-y, marking a return to growth after four quarters of decline. We expect the growth driver to be the GC&MP segment, which we expect will hold its own (we estimate +15% y-o-y). We estimate NW&FT sales of SEK 11m, -13% y-o-y. However, it is important to note that NW&FT witnessed price decreases in Q2'24, therefore comps this quarter will be based on a higher price component and comps will be easier from Q2. For FW, we expect a stable quarter (+1% y-o-y) due to a continued sluggish construction market. On EBIT, we estimate SEK 0.5m (0.2m).
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.